Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Virtual Twins: Their Roles In Healthcare, Drug Discovery, And Pandemic Response

    Jul 9, 2020, 10:10 AM by Michael Croft

    Bio-IT World | In a world that has shifted to virtual everything—work, recreation, connection—it’s no wonder that virtual or digital twins are getting more attention. It’s certainly a favorite term of marketers: we are creating digital twins for everything from people to businesses, instruments to labs.

    Full story
  • HENRY SCHEIN MEDICAL ANNOUNCES EXPANSION OF MEDPOD’S TELEMEDICINE SOLUTIONS WITH INTEGRATION OF VISUALDX

    Jul 9, 2020, 10:02 AM by Michael Croft
    MELVILLE, NY, UNITED STATES - Jul 9, 2020 - Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. and exclusive distributor of Medpod, Inc
    Full story
  • SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience

    Jul 8, 2020, 11:17 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Jul 8, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and SCL Health, a faith-based nonprofit health system providing care across Colorado, Kansas, and Montana, today announced that SCL Health has selected Kyruus’ patient access and provider data management platform to enable its digital access initiatives
    Full story
  • Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain

    Jul 8, 2020, 09:53 AM by Michael Croft
    REDCAR, UNITED KINGDOM - Jul 8, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19
    Full story
  • Can Your Data Protection Strategy Survive A Pandemic?

    Jul 8, 2020, 08:15 AM by Michael Croft

    Bio-IT World Contributed Commentary | Across the world, scientific laboratories have redirected their research efforts toward the global COVID-19 pandemic. Achieving the goal of understanding and treating the virus requires the generating and gathering of data. Like any big shift in the way we generate, manage, or use data, this will have implications for the datacenter.

    Full story
  • Optibrium and North Carolina School of Science and Mathematics mark five years of education collaboration with summer school ‘Computing COVID-19’

    Jul 8, 2020, 06:01 AM by Michael Croft
    CAMBRIDGE, UK AND DURHAM, NC, USA, UNITED KINGDOM - Jul 8, 2020 - Optibrium™, a leading provider of software and services for drug discovery, and the North Carolina School of Science and Mathematics (NCSSM), the states leading high school for science, technology and math education, are celebrating five years of an education support collaboration
    Full story
  • Boehringer Ingelheim Extends TrialScope Partnership

    Jul 7, 2020, 12:05 PM by Michael Croft
    JERSEY CITY, NJ, UNITED STATES - Jul 7, 2020 - In its ongoing commitment to maintaining compliance with ever-changing global clinical trial disclosure regulations, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five years
    Full story
  • InSysBio to announce the launch of its new tool Heta compiler

    Jul 7, 2020, 05:04 AM by Michael Croft
    MOSCOW, RUSSIA - Jul 6, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms
    Full story
  • OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract.

    Jul 6, 2020, 17:12 PM by Michael Croft
    GOLETA, CA, UNITED STATES - Jul 6, 2020 - FOR IMMEDIATE RELEASE
    OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract
    Full story
  • Bio-IT World Announces 2020 Innovative Practices Award Winners

    Jul 6, 2020, 09:00 AM by Michael Croft

    Bio-IT World | Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance have been announced as the winners of the 2020 Innovative Practices Awards.

    Full story
  • How The SARS-CoV-19 Virus Attacks Cells, Other COVID-19 News

    Jul 2, 2020, 08:25 AM by Michael Croft

    Bio-IT World | New research shows how the SARS-CoV-19 virus shifts the cell's activity to promote its own replication and to infect nearby cells. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.

    Full story
  • Kyruus Obtains AVIA Recognition for Its Enterprise-Wide Patient Access Platform

    Jul 1, 2020, 11:36 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Jul 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that AVIA, the nation's leading digital transformation partner for healthcare organizations, has recognized its full suite of technology solutions with AVIA Vetted and/or Market Validated designations for 2020
    Full story
  • Saving Lives with Great Research Requires a Research Tech Rethink

    Jul 1, 2020, 08:10 AM by Michael Croft

    Bio-IT World Contributed Commentary | Researchers are working hard to provide the evidence needed for fact-based decisions addressing everything from developing new vaccines, to ensuring existing treatments are being used to their best advantage. Now, more than ever, the time and funding allocated for these projects must be used to their fullest extent.

    Full story
  • Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants

    Jul 1, 2020, 03:41 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Jul 2, 2020 - As COVID-19 is still spreading all over the world, the global confirmed cases have jumped to 9 million
    Full story
  • CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations

    Jul 1, 2020, 03:38 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Polyethylene glycol (PEG), a biocompatible, synthetic, hydrophilic polyether compound, is non-toxic, FDA-approved, and is frequently used in many biomedical applications including bioconjugation, drug delivery, surface functionalization, and tissue engineering
    Full story
  • Creative Biolabs Updated Exosome Isolation and Profiling Service to Facilitate Related Research

    Jun 30, 2020, 23:11 PM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Recently, exosomes, which have specialized functions and play a key role in different physiological processes and pathological conditions, are attracting increasing attention in their clinical applications for prognosis, diagnosis, drug delivery, and vaccine development
    Full story
  • Kyruus Achieves SOC 2 Type II Attestation

    Jun 29, 2020, 11:31 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Jun 29, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that it has successfully completed its System and Organization Controls (SOC) 2 Type II examination by an independent auditor
    Full story
  • Genomics England launches next-generation research platform central to UK COVID-19 response

    Jun 29, 2020, 09:15 AM by Michael Croft
    LONDON, UK - Jun 29, 2020 - Genomics England (GEL) has today launched a next-generation genomic research platform that will play a key role in the research response to COVID-19
    Full story
  • Bringing Light—and Value—to Dark Data in Research & Design

    Jun 29, 2020, 08:35 AM by Michael Croft

    Bio-IT World Contributed Commentary | Data are often recognized as a top asset of organizations in any field, including the biosciences, but the way it’s handled may not adequately reflect this. One explanation for this mismatch is that the amount of data being produced every day is enormous—but not necessarily accessible.

    Full story
  • AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

    Jun 29, 2020, 04:58 AM by Michael Croft
    NY, NY, UNITED STATES - Jun 23, 2020 - As an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applications, the New York-based company AI & Medicine recently announces to release biomarker discovery and targeted proteomics services for researchers worldwide
    Full story
  • «
  • 201 (current)
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy